Loading...
•
Jun 30, 2020
Stryker Q2 2020 Earnings Report
Stryker's Q2 2020 results were negatively impacted by COVID-19, with net sales decreasing by 24.3% and a reported EPS loss of $0.22.
Key Takeaways
Stryker's Q2 2020 results were significantly impacted by the COVID-19 pandemic, leading to a 24.3% decrease in reported net sales to $2.8 billion. The company reported a net loss of $83 million, or $0.22 per diluted share, but adjusted EPS was $0.64. Due to the uncertain scope and duration of the pandemic, Stryker is not providing third quarter or full-year organic sales growth or earnings guidance for 2020.
Reported net sales decreased 24.3% to $2.8 billion.
Organic net sales decreased 24.0%.
Reported EPS decreased 117.5% to ($0.22).
Adjusted EPS decreased 67.7% to $0.64.
Stryker
Stryker
Stryker Revenue by Segment
Revenue by Segment
Orthopaedics Revenue
CapyFin.com Forward Guidance
Due to the uncertain scope and duration of the pandemic, and uncertain timing of global recovery and economic normalization, Stryker is unable to estimate the overall impacts on our operations and financial results, which could be material. Accordingly, Stryker will not be providing third quarter or full-year organic sales growth or earnings guidance for 2020.